|Bid||20.12 x 900|
|Ask||20.30 x 900|
|Day's Range||19.81 - 21.10|
|52 Week Range||3.63 - 22.16|
|Beta (5Y Monthly)||0.61|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.01 (0.07%)|
|Ex-Dividend Date||Sep 14, 2020|
|1y Target Est||N/A|
Shares of Owens & Minor jumped 47.3% on Thursday after the global healthcare solution provider raised its 2020 earnings outlook for the second time in the last two months.Owens & Minor (OMI) now projects adjusted EPS between $1.75 and $1.90, up from its previous guidance range of $1.00-$1.20. On July 21, the company had revised upward its full-year 2020 adjusted EPS guidance to $1.00-$1.20 from $0.50-$0.60.The company cited better-than-expected manufacturing output and improved operating efficiencies as the main reasons behind the upbeat earnings outlook. Additionally, the company pointed out strong demand for PPE kits amid the COVID-19 pandemic, higher-than-expected elective procedures volume, and deployment of PPE related production equipment in the U.S. ahead of schedule, to benefit bottom-line results.Owens & Minor’s CEO Edward A. Pesicka said, "I continue to be very proud of our teammates’ ability to rapidly bring additional, U.S.-based PPE production online ahead of schedule and increase product output. This is enabling us to continue to reduce the gap between customer demand and supply." (See OMI stock analysis on TipRanks).On August 11, Robert W. Baird analyst Eric Coldwell designated Owens & Minor as a “Fresh Pick” and advised investors to take advantage of the “unusual opportunity” in the stock. Coldwell believes that the company’s new leadership can accelerate growth amid the ongoing pandemic.Currently, the Street is sidelined on the stock as shares have put on a tremendous rally recently. The Hold analyst consensus is based on 2 Hold ratings, 2 Buys, and 2 Sells. With shares up nearly 293% year-to-date, the average analyst price target of $13.56 implies a downside potential of 33.2% from current levels.Related News: Gilead To Pay $97M To Settle Kickback Debacle Over Letairis Drug Darden Restaurants Gains 6% On 2Q Profit Guidance Penn National Dips 8% On $1B Share Offering; Deutsche Sees 66% Downside More recent articles from Smarter Analyst: * Vail Resorts Posts Wider 4Q Loss, Shares Gain On Season Pass Sales * IBEX Rises 3% On Upbeat 4Q Sales Results * E.W. Scripps Jumps 8% On Warren Buffett-Backed ION Media Deal * Lululemon vs Columbia Sportswear: Which Retail Stock Has Healthier Prospects?
Shares of Owens & Minor Inc. shot up 57.4% on heavy volume in midday trading Thursday, enough to pace all of the NYSE's gainers, after the maker of medical surgical products raised its full-year profit outlook for the second time in two months, citing better-than-expected manufacturing output. Trading volume swelled to 11.7 million shares, compared with the full-day average of about 1.1 million shares. The stock was on track for the highest close since January 2018, and the biggest one-day gain since it rocketed 81.4% on July 27, when it more than doubled its 2020 earnings outlook. The company said earlier Thursday that it now expects 2020 adjusted earnings per share of $1.75 to $1.90, up from previous guidance of $1.00 to $1.20. Besides better-than-expected manufacturing output, the company said deployment of personal protective equipment (PPE) was ahead of schedule, elective procedure volume was slightly above previously expected levels and demand for PPE continued to be strong. The stock has rocketed more than fourfold (up 319.9%) year to date, while the SPDR Health Care Select Services ETF has slipped 0.3% and the S&P 500 has tacked on 0.9%.
Shares of Owens & Minor (NYSE: OMI) were soaring 55.2% higher as of 11:38 a.m. EDT on Thursday. The huge jump came after the healthcare solutions company raised its full-year 2020 earnings guidance from a range of $1 to $1.20 per share to a range of $1.75 to $1.90. The main reason for Owens & Minor's bullishness can be summed up in just three letters: PPE.